With the advent of a wide variety of new treatments, traditional chemotherapy and radiation therapy have faded into the background due to serious side effects. Treatment of non-Hodgkin's lymphoma abroad, in clinics in Israel, Turkey, Germany, Korea, China, Singapore and India, is safer than in Russia, as it is formed on the basis of individual patient data, which include:
- type and pattern of lymphoma growth;
- stage of the disease;
- the general state of the patient's health.
Advanced treatment methods for non-Hodgkin's lymphoma abroad
In hospitals in China, Germany, Korea, and Singapore, non-Hodgkin's lymphoma is treated under the guidance of a team of doctors, including medical and radiation oncologists, radiologists, and other specialists. If a patient is diagnosed with slow-growing lymphoma, active monitoring is prescribed with regular body scans. Many patients have no symptoms and do not need any treatment for many years.
Chemotherapy
Chemotherapy has been an effective treatment for non-Hodgkin's lymphoma for many decades. In Korea and Singapore, modern R-CHOP therapy, which includes the monoclonal antibody Rituximab, is provided for aggressive B-cell cancer.
In Israel, chemotherapy is performed using liposomal drug delivery, which increases their effectiveness. Since chemotherapy drugs reduce the concentration of certain types of blood cells, patients are injected with hematopoietic growth factors.
Targeted therapy
In India and Turkey, patients can receive targeted therapy based on an individual assessment of their non-Hodgkin's lymphoma development. Biologically targeted drugs disable the molecular pathways that stimulate the growth and division of specific cancer cells. These new methods are less toxic than traditional chemotherapy.
In German hospitals, patients can participate in clinical trials of innovative drugs that have demonstrated their effectiveness and are awaiting FDA approval. The cost of targeted therapy becomes known only after examination of the patient.
Immunotherapy
Israel and Germany are international leaders in the development of immunotherapy for cancer treatment. Today, clinics in these countries use several main areas of immune therapy for non-Hodgkin's lymphoma, including CAR T-cell therapy, bispecific T-cell activator (BiTE) and checkpoint inhibitors such as Nivolumab (Opdivo).
Radiation therapy
Many types of lymphoma are very sensitive to radiation therapy. Hospitals in Korea and China use the latest focused radiation technologies that minimize damage to healthy cells. For example, advanced intensive modulated radiation therapy uses modern computer programs to calculate and deliver rays directly to cancer cells from different angles. PET-CT scanning is used for accurate treatment planning.
Stem cell transplantation is performed in many international cancer centers for patients with non-Hodgkin's lymphoma.
South Korea
China
India
